Medtronic plc (MDT)
Coverage summary
Aardvark Labs Capital Research has covered Medtronic plc (MDT) since August 20, 2025. The company is in the Healthcare sector. This page lists 5 reports: 5 earnings recaps.
The latest is the Q1 FY27 Earnings Recap, published September 4, 2026. The current rating is Outperform, unchanged since the Q2 FY26 Earnings Recap of November 19, 2025. The rating has changed once since coverage began.
Translations: 5 in Chinese.
Rating history
All MDT reports
Recap: Q1 FY27
Strip the 53rd Week and It Still Accelerates: Seven Percent Underlying, a Revenue Raise, and a Beat Management Chose to Spend
Recap: Q4 FY26
The Washout Meets the Proof: A Ten-Year-Best Year Closes at Thirteen Times Earnings, Margins Inflect, and Symplicity Finally Gets a Number — Maintain Outperform
Recap: Q3 FY26
Six Percent Growth, Sold: The Telegraphed Trough Quarter Arrives and the Street Reads the FY27 Footnotes — Maintain Outperform
Recap: Q2 FY26
The Show-Me Quarter Showed Up: CAS +71%, a Best-Case NCD, and the First Organic Guide Raise of the Year — Upgrading to Outperform
Recap: Q1 FY26
Eleven Straight Quarters of Mid-Single-Digit Growth — and an Activist Who Agrees That Isn't Enough. Initiating at Hold